戻る Agenda
SESSION 3: SIGNAL MANAGEMENT – REGULATORY EXPECTATIONS (1)
Session Chair(s)
Philip Jones
Disease Area Cluster Lead in Safety Surveillance and Risk Management
Pfizer Ltd., United Kingdom
We will review the latestregulatory requirements on implementing and maintaining a signal management process. Again, practical exercises will allow participants to understand how they can develop a policy in signal management, and cope with any inspection on this topic.
Speaker(s)
SIGNAL MANAGEMENT – REGULATORY EXPECTATIONS
Philip Jones
Pfizer Ltd., United Kingdom
Disease Area Cluster Lead in Safety Surveillance and Risk Management